CENRIFKI
Live / Applied — First extension granted (statement of use) (as of 16 Mar 2026)
What this means for you
Not registered yet, but its 23 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99150543
- Mark type
- Stylized text
- Filed
- 23 Apr 2025
- Published for opposition
- 16 Sept 2025
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of multiple sclerosis
Owner
- Principia Biopharma Inc., Morristown, NJ, US
- Principia Biopharma Inc., Bridgewater, NJ, US
Prosecution history
- 15 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Mar 2026 — SOU EXTENSION 1 GRANTED
- 16 Mar 2026 — SOU EXTENSION 1 FILED
- 16 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Sept 2025 — PUBLISHED FOR OPPOSITION
- 10 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Aug 2025 — ASSIGNED TO EXAMINER
- 26 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 26 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED